NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock (NMTC)

CUSIP: 64130M209

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / Common Stock
Shares outstanding
8,477,622
Total 13F shares
722,249
Share change
+131,117
Total reported value
$866,359
Put/Call ratio
1.4%
Price per share
$1.20
Number of holders
18
Value change
+$155,582
Number of buys
12
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 64130M209?
CUSIP 64130M209 identifies NMTC - NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of NMTC - NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
AWM Investment Company, Inc.
13F
Company —
class O/S missing
1,363,331
 $2,304,000 — 30 Sep 2022
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.4%
114,563
 $193,000 — 30 Sep 2022
13F
VANGUARD GROUP INC
13F
Company
0.98%
82,918
 $141,000 — 30 Sep 2022
13F
DRIVE WEALTH MANAGEMENT, LLC
13F
Company
0.79%
66,667
 $113,000 — 30 Sep 2022
13F
MAI Capital Management
13F
Company
0.59%
50,000
 $85,000 — 30 Sep 2022
13F
STATE STREET CORP
13F
Company
0.42%
35,899
 $61,000 — 30 Sep 2022
13F
JANE STREET GROUP, LLC
13F
Company
0.24%
20,282
 $34,000 — 30 Sep 2022
13F
NORTHERN TRUST CORP
13F
Company
0.18%
15,376
 $26,000 — 30 Sep 2022
13F
Newport Capital Group, LLC
13F
Company
0.22%
18,348
 $24,000 — 30 Sep 2022
13F
Tower Research Capital LLC (TRC)
13F
Company
0.06%
5,325
 $9,000 — 30 Sep 2022
13F

Institutional Holders of NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock (NMTC) as of Q4 2022

As of 31 Dec 2022, NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock (NMTC) was held by 18 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 722,249 shares. The largest 10 holders included Mayo Clinic, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, DRIVE WEALTH MANAGEMENT, LLC, MAI Capital Management, CITADEL ADVISORS LLC, STATE STREET CORP, JANE STREET GROUP, LLC, and NORTHERN TRUST CORP. This page lists 18 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders
9
Q4 2022 holders
18
Holder diff
9
Investor Q3 2022 Shares Q4 2022 Shares Share Diff Share Chg % Q3 2022 Value $ Q4 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .